De nordiska börserna inledde veckans handel med uppgångar på samtliga huvudindex och fortsatte i linje med förra veckans ...
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.
Bangkok Post on MSN23h
Novo Nordisk and Bangkok Unite for a Healthier FutureTo mark World Obesity Day 2025, Novo Nordisk participated in the Chula Obesity Day event, organised by Chulalongkorn University. As part of the session 'How Cities and Partnerships Drive a Sustainable ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback